HOME >> BIOLOGY >> NEWS
The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany

This release is also available in German.

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) sees the draft amendment to the Genetic Engineering Act as a restriction on innovation and research in Germany. If the amendment were to be passed in its current form it runs the risk, in the opinion of the DFG, of putting German researchers at a considerable disadvantage on the international playing field. This is the key theme of the statement on the law on genetic engineering recently released by the DFG.

The DFG primarily opposes three aspects of the draft amendment. For instance, the draft put forward by the German federal government assumes that a particular risk is automatically attached to the introduction of genetically modified organisms (GMOs). In the opinion of the DFG this assumption is not backed up by experimental data.

The inappropriate risk assessment leads to increased red tape and hampers the transfer of the findings of basic research to economically viable processes and products. The draft amendment also intends to hold users of genetically modified organisms responsible for "intrusion" by GMOs into conventionally or ecologically produced seed. However, it is not possible in principle to prevent such cross breeding of genetically modified organisms. If the liability proposed in the amendment is enforced, research involving genetically modified organisms or their release will barely be possible in Germany any longer.

Thirdly, the DFG is against the planned splitting of the Central Commission for Biological Safety into two committees and the inclusion of members who do not have relevant technical expertise. The DFG does not perceive a need for new boards, new bureaucratic regulations or additional authorities.

The envisaged establishment of a federal register for recording the location of GMOs and registers for each of the 16 st
'"/>

Contact: Prof. Dr. Jrg Hacker
j.hacker@mail.uni-wuerzburg.de
49-0-9131-31-2575
Deutsche Forschungsgemeinschaft
6-Jul-2004


Page: 1 2

Related biology news :

1. Plants will not save us from greenhouse gases
2. Environmental decontamination, greenhouse gases, and the genome of a methane-loving bacterium
3. Spring through fall, cities are greener longer than neighboring rural regions
4. Urban heat islands make cities greener
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. New space-borne instrument to track greenhouse gases, ozone destroyers, and other pollutants
7. UK small firms pay lip service to green issues
8. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
9. White tea beats green tea in fighting germs
10. Improved crop production and fewer greenhouse gases
11. Emerging frontiers genomics grant for blue-green bacteria

Post Your Comments:
(Date:10/30/2014)... A UT Arlington bioengineering professor has received a ... aims to regenerate cartilage tissue and reduce osteoarthritis ... the injection of microscaffolding made of biodegradable polymers., ... of the bioengineering department, said the research is ... injured on the battlefield., "We,ve found that if ...
(Date:10/30/2014)... This news release is available in German . ... we as individuals prompt our fellow humans to behave ... to social dilemmas in game theory. Previous studies assumed ... large groups. Nonetheless, scientists from the Max Planck Institute ... us can exert an influence on the cooperative behaviour ...
(Date:10/30/2014)... October 30, 2014 – Bacteria in the gastrointestinal ... for digestion. Yet, these same bacteria can induce ... they penetrate the gut and enter the bloodstream. ... to protect the body, chronic or systemic inflammation ... research has established the involvement of inflammatory processes ...
Breaking Biology News(10 mins):UTA researcher uses microscaffolding injections to mend cartilage, prevent osteoarthritis 2Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics 2
(Date:10/30/2014)... Investor-Edge has initiated coverage on the following ... (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: ... and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on ... . On Wednesday, October 29, 2014, the ... Jones Industrial Average declined 0.18%, to finish the day ...
(Date:10/30/2014)... Illinois (PRWEB) October 30, 2014 ... and Cellular Medicine Showcase in Chicago, leading applied ... Orthopedic Surgeon, Dr. Wade McKenna presented talks on ... and Orthopedic Surgical Applications For Stem Cells. , ... amniotic membrane and the properties of AlphaGEMS that ...
(Date:10/30/2014)... Spartan Bioscience announced today that Health Canada ... It detects CYP2C19 genetic mutations in less than 60 ... RX CYP2C19 System is the first near-patient DNA test ... Due to the system’s ease of use, Health Canada ... professionals such as doctors, nurses, pharmacists, and laboratory technicians, ...
(Date:10/30/2014)... 30, 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ... management will present a company overview at the Nomura Biotechnology ... in Boston, MA. A ... "Investors & Media" section of the Company,s website, www.isispharm.com ... within 48 hours and will be archived for a limited ...
Breaking Biology Technology:Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
Cached News: